A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
Recruiting · NCT06858397 · Registry updated 2025-11-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease | Fabry Disesase | Recruiting | Phase 1 / Phase 2 | 2025-11-04 | NCT06858397 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GC Biopharma Corp | 9 |
| Hanmi Pharmaceutical Company Limited | 15 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centro Medico IPAM | Rosario | Argentina | 1 |
| Children's Hospital Medical Center | Cincinnati | United States | 2 |
| David Geffen School of Medicine UCLA, UCLA Health | Los Angeles | United States | 1 |
| Hospital Italiano de Buenos Aires | Buenos Aires | Argentina | 25 |
| Lysosomal and Rare Disorders Research and Treatment Center | Fairfax | United States | 1 |
| Pusan National University Children's Hospital in Yangsan | Yangsan | South Korea | 1 |
| University of Kansas School of Medicine | Kansas City | United States | 1 |
| University of Minnesota | Minneapolis | United States | 325 |
| University of Pittsburgh Medical Center Children's Hoispital of Pittsburgh | Pittsburgh | United States | 1 |
| Yonsei University, College of Medicine | Seoul | South Korea | 1 |